We are delighted to share that the HVS Mitral & Tricuspid Valve Database is now operational! This significant database is a detailed longitudinal cohort study that captures essential information on patient demographics, procedural specifics, and outcomes for individuals with mitral and/or tricuspid valve disease who are undergoing either surgical or transcatheter interventions.

Building on the success of the Aortic Valve Database, these international databases have been developed to ensure a robust patient cohort. This will facilitate the evaluation of surgical guidelines, as well as the decision-making process regarding valve repair versus replacement in cases of valve stenosis or regurgitation. It will ascertain a systematic uniform registration of patient characteristics, in-depth procedural aspects and follow-up.

The registry is open for participation from centers that perform these specialized interventions. Patients can be included consecutively or as part of a project. Projects enable centers to enroll specific patient groups within a set timeframe, and we welcome centers to propose new projects or join existing ones.

Centers specializing in these interventions are encouraged to apply. To apply or propose a project, please contact us.

For additional details on the HVS Mitral & Tricuspid Valve Database, please visit our website.

For any inquiries or more information, please don’t hesitate to get in touch. Let’s collaborate to forge the future of cardiac care!

We are proud to announce a remarkable milestone for the HVS Aortic Valve Database: the inclusion of 10.000 patients. This success is thanks to the commitment of our participating centers and patients. Their contributions have allowed us to grow and welcome even more members to our database.

This expansion marks a significant milestone and underscores our mission to enhance cardiac care through collective data. We are grateful to everyone involved for making this possible.

The HVS Mitral & Tricuspid Valve Database has embraced Castor EDC as our new data management platform. With its user-friendly interface and the functionality to send questionnaires directly to patients, Castor EDC marks a significant advancement in our data collection and analysis capabilities.

In addition, we are gearing up for the HVS Aortic Valve Database’s transition from Telemedicine Technologies to Castor EDC. Effective January 1, 2025, the Aortic Valve Database will be hosted on Castor EDC, ensuring continuity and enhanced efficiency in our data management practices. Participating centers will receive concise instructions for a smooth transition to the new platform. Our team is dedicated to upholding data integrity and patient care standards and will offer training and support for any inquiries.